Dr. Djordje Atanackovic, MD is Professor of Medicine, and Medical Director of the Fannie Angelos Cellular Therapeutics Laboratory at the Greenebaum Cancer Center and Director of Cellular and Vaccine Immunotherapy at the Greenebaum Cancer Center.
Preferred protocol in the first-line setting and outside of clinical studies would be single transplant with or without maintenance therapy depending on the risk profile of the patient. However, we always prefer for a patient to be treated within a clinical study and in that case my focus would be immunotherapy.
years treating myeloma: 18
Number of Myeloma Patients Treated Annually: 200-500
Details & contact info
Cider Alley Ridgleys Delight
Baltimore, MD, United States, 21201
Send a message to Djordje Atanackovic, MD